| Measure Code | Measure Title | Performance Rate | Patient Count | Star Value | Five Star Benchmark | Collection Type |
|---|---|---|---|---|---|---|
| IA_EC_BE_13 | Regularly assess the patient experience of care through surveys, advisory councils and/or other mechanisms. | |||||
| IA_EC_EPA_2 | Use of telehealth services that expand practice access | |||||
| MIPS_EC_001_overall | Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) | 84 | 172 | EHR | ||
| MIPS_EC_005_overall | Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 79 | 66 | EHR | ||
| MIPS_EC_007_overall | Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) | 87 | 60 | EHR | ||
| MIPS_EC_047_overall | Advance Care Plan | 77 | 772 | 4 | 100 | REG |
| MIPS_EC_008_overall | Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) | 79 | 58 | EHR | ||
| MIPS_EC_118_overall | Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%) | 77 | 135 | REG | ||
| MIPS_EC_119_overall | Diabetes: Medical Attention for Nephropathy | 67 | 172 | 3 | 100 | EHR |
| MIPS_EC_128_overall | Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan | 98 | 991 | 4 | 100 | REG |
| MIPS_EC_226_overall | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 40 | 127 | 2 | 100 | EHR |
| MIPS_EC_226_screenedForUse | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 61 | 596 | EHR | ||
| MIPS_EC_226_tobacco | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 58 | 596 | EHR | ||
| MIPS_EC_441_overall | Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control) | 49 | 39 | REG | ||
| PI_EC_EP_1 | e-Prescribing | 91 | 220 | 2 | 100 | REG |
| PI_EC_ONCACB_1 | ONC-ACB Surveillance Attestation | |||||
| PI_EC_ONCDIR_1 | ONC Direct Review Attestation | |||||
| PI_EC_PEA_1 | Provide Patients Electronic Access to Their Health Information | 73 | 404 | 3 | 100 | REG |
| PI_EC_PHCDRR_5 | Clinical Data Registry Reporting | |||||
| QCDR_EC_ACCPIN7_overall | Peripheral Artery Disease: Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk | 73 | 45 | QCDR | ||
| PI_EC_PHCDRR_5_MULTI | Clinical Data Registry Reporting for Multiple Registry Engagement | |||||
| PI_EC_PPHI_1 | Security Risk Analysis |